Effects of treatment of ectopic pregnancy with methotrexate or salpingectomy in the subsequent IVF cycle

Reprod Biomed Online. 2013 May;26(5):449-53. doi: 10.1016/j.rbmo.2013.01.018. Epub 2013 Feb 9.

Abstract

Ectopic pregnancy is a known risk for patients treated with IVF. The objective of this study was to evaluate the effect of methotrexate (MTX) and laparoscopic salpingectomy as treatments of ectopic pregnancy on ovarian response during IVF cycles. Data of all women treated for ectopic pregnancy as a result of IVF treatment were evaluated; the study included women who had an unruptured ectopic pregnancy after IVF treatment that was treated with either MTX or laparoscopic salpingectomy and underwent a subsequent IVF cycle. The main outcome measures were baseline serum FSH concentrations and ovarian response in the subsequent IVF cycle after treatment of ectopic pregnancy. Of a total of 58 patients, 36 were previously treated with MTX and 22 others by salpingectomy. No significant differences were observed between the MTX and the salpingectomy groups in the parameters of ovarian response in the subsequent IVF cycle.

Publication types

  • Comparative Study

MeSH terms

  • Abortifacient Agents, Nonsteroidal / pharmacology
  • Abortifacient Agents, Nonsteroidal / therapeutic use*
  • Adult
  • Biomarkers / blood
  • Chorionic Gonadotropin / blood
  • Female
  • Fertilization in Vitro*
  • Humans
  • Methotrexate / pharmacology
  • Methotrexate / therapeutic use*
  • Ovary / drug effects
  • Ovary / physiology
  • Ovulation Induction
  • Pregnancy
  • Pregnancy Outcome*
  • Pregnancy, Ectopic / therapy*
  • Retrospective Studies
  • Salpingectomy*
  • Treatment Outcome

Substances

  • Abortifacient Agents, Nonsteroidal
  • Biomarkers
  • Chorionic Gonadotropin
  • Methotrexate